Condensed Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2020 |
Sep. 30, 2019 |
Sep. 30, 2020 |
Sep. 30, 2019 |
|
| Revenue: | ||||
| Total revenue | $ 1,797,833 | $ 5,371,646 | $ 6,956,122 | $ 16,117,583 |
| Costs and expenses: | ||||
| Cost of ancillary products and assembled components | 11,142 | 37,674 | 40,855 | 167,009 |
| Selling, general and administrative | 1,833,723 | 3,645,319 | 7,264,410 | 10,126,029 |
| Research and development | 97,081 | 208,253 | 391,333 | 685,693 |
| Depreciation and amortization | 575,637 | 476,112 | 1,499,927 | 1,439,220 |
| Share-based compensation | 178,553 | 242,016 | 512,818 | 678,199 |
| Total costs and expenses | 2,696,136 | 4,609,374 | 9,709,343 | 13,096,150 |
| (Loss) income from operations | (898,303) | 762,272 | (2,753,221) | 3,021,433 |
| Other income (expense): | ||||
| Interest income | 1,412 | 25,326 | 25,313 | 45,891 |
| Interest expense | (162,082) | (165,706) | (506,922) | (503,262) |
| Share redemption consideration | (195,482) | (195,482) | (586,446) | (315,293) |
| Foreign currency exchange gain (loss) | 20,014 | (69,470) | (95,976) | (57,299) |
| Change in estimated fair value of interest rate swap liability | 55,330 | 13,162 | 21,650 | (78,440) |
| Other non-recurring income | 15,320 | 15,320 | ||
| Total other expense | (265,488) | (392,170) | (1,127,061) | (908,403) |
| (Loss) income before benefit (provision) for income taxes | (1,163,791) | 370,102 | (3,880,282) | 2,113,030 |
| Benefit (provision) for income taxes | (133,708) | 210,132 | 492,807 | (17,189) |
| Net (loss) income | $ (1,297,499) | $ 580,234 | $ (3,387,475) | $ 2,095,841 |
| Net (loss) income per share: | ||||
| Basic | $ (0.07) | $ 0.03 | $ (0.18) | $ 0.07 |
| Diluted | $ (0.06) | $ 0.03 | $ (0.17) | $ 0.07 |
| Weighted-average shares outstanding: | ||||
| Basic | 19,745,525 | 17,774,022 | 18,675,769 | 28,083,665 |
| Diluted | 20,475,085 | 19,102,709 | 19,483,464 | 29,672,645 |
| Product Lease Royalties And Other | ||||
| Revenue: | ||||
| Total revenue | $ 1,797,833 | $ 5,371,646 | $ 6,956,122 | $ 16,117,583 |
| X | ||||||||||
- Definition Fair value adjustment of derivative liability. No definition available.
|
| X | ||||||||||
- Definition Share redemption consideration. No definition available.
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|